Overview

Photodynamic Therapy (PDT) With Levulan and Blue Light for the Treatment of Actinic Cheilitis

Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of PDT with blue light and topical Levulan in the treatment of actinic cheilitis.
Phase:
Phase 4
Details
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Collaborator:
DUSA Pharmaceuticals, Inc.
Treatments:
Aminolevulinic Acid